GLP-1 is an incretin hormone that stimulates insulin secretion in a glucose-dependent manner, reducing hypoglycaemia risk The hormone slows gastric emptying and suppresses appetite through receptors in the pancreas, brain, and gastrointestinal tract GLP-1 receptor agonists (semaglutide, liraglutide, dulaglutide) are MHRA-approved for type 2 diabetes and weight management Common side effects include nausea, vomiting, and diarrhoea due to delayed gastric emptying and altered gut motility Patients should seek urgent medical attention for severe abdominal pain with persistent vomiting, as this may indicate pancreatitis GLP-1 medications do not directly impair digestive enzyme production, and routine enzyme supplementation is not clinically indicated Table of Contents What Does GLP-1 Stand For
Personalized Protocol Planning Usage guidance tailored to individual goals
The phenotypic plasticity of microglia, astrocytes, and peripheral immune cells plays an important role in maintaining this equilibrium
Born in Kent in 1942, Bloom did his undergraduate medical training at the University of Cambridge in 1979 and a DSc degree at the University of London in 1982
Sublingual B12 Supplementation: Pros and Cons Pros Easily absorbed: Sublingual B12 tablets are absorbed into the bloodstream through the mucous membranes when placed under the tongue
Similarly, the SUSTAIN trials for diabetes management showed comparable trends